Hypertension Clinical Trials in San Francisco, California

4 studies are recruiting for hypertension in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

    A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Sutter Valley Hospitals, San Francisco, California
    Locations
    131 in total
    Run by
    Orchestra BioMed, Inc

    See if you can join NCT06059638 on ClinicalTrials.gov

  2. Secondhand Tobacco Smoke and Cardiovascular Disease

    This is a double-blind randomized placebo-controlled crossover clinical trial of efficacy and safety of an FDA-approved angiotensin receptor blocker (losartan) to improve cardiopulmonary outcomes in individuals with pre-Chronic Obstructive Pulmonary Disease (COPD) due to prolonged exposure to secon…

    Stage
    Phase 4
    Ages
    40 and older
    Site
    San Francisco Veterans' Affairs Medical Center, San Francisco, California
    Run by
    University of California, San Francisco

    See if you can join NCT04715568 on ClinicalTrials.gov

  3. Oura Blood Pressure Profile Study

    The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.

    Stage
    Not phased
    Ages
    22 and older
    Site
    Ouraring, San Francisco, California
    Run by
    Ouraring Inc.

    See if you can join NCT07267871 on ClinicalTrials.gov

  4. Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

    Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to not only include a bridge to transplantation strategy, but also for those individuals who suffer from…

    Stage
    Not phased
    Ages
    18 to 100
    Site
    UCSF, San Francisco, California
    Locations
    7 in total
    Run by
    International Consortium of Circulatory Assist Clinicians

    See if you can join NCT06039176 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.